IFNG and neoplasm: IFNγ can activate cytotoxic T cells and macrophages to kill tumor cells; meanwhile, persistent expression of IFNγ can induce expression of immune checkpoint molecules such as PD-L1 on tumor cells and antigen-presenting cells to diminish T cell antitumor activities (69).